Clinical Trial Packaging Market

Clinical Trial Packaging Market Research, 2031

The global clinical trial packaging market size was valued at $2.58 billion in 2021, and is projected to reach $6.21 billion by 2031, growing at a CAGR of 9.1% from 2022 to 2031. The type of packaging used for the clinical trial generally consists of the primary containers that are generally blisters and vials with a secondary packaging over it that is composed of a carton and a label. The demand for clinical trial packaging industryis growing due to the technological developments in the medical device industry that is leading to increase its usage for the pharmaceutical applications.

The outbreak of COVID-19 had an positive impact on the clinical trial packaging as research on vaccine increased tremendously and therefore led to increase in demand for clinical trial packaging.

In addition, the demand for innovative packaging solutions are growing that is leading to adoption of environmentally friendly packaging material that is more ecofriendly and could be recycled easily. Such factor are driving the clinical trial packaging market growth.

However, strict rules and regulations by the government across the world is a factor limiting the growth of clinical trial packaging market due to restrictions in usage of certain packaging materials such as plastic.

Furthermore, during the outbreak of the COVID-19 pandemic, construction, manufacturing, hotel, and tourism industries were majorly affected. Manufacturing activities were halted or restricted. Construction and transportation activities, along with their supply chains, were hampered on a global level. This led to decline in manufacturing of clinical trial packaging as well as their demand in the market, thereby restraining the growth of the clinical trial packaging market share. Conversely, industries are gradually resuming their regular manufacturing and services. This is expected to lead to re-initiation of clinical trial packaging companies at their full-scale capacities, that helped the market to recover by end of 2021.

On the contrary, technological advancements over the packaging method is leading to new form of packaging systems that is more user friendly. Thus, such a factor is expected to offers new opportunities for the growth of the clinical trial packaging market.

The clinical trial packaging market is segmented into Packaging Type, Material and End-user. On the basis of packaging type, it is further classified into syringes, vials & ampoules, bottles, bags & pouches and others. By material, it is divided into plastic, glass, metal, paper, and corrugated fiber. By end user, it is categorized into research laboratories, clinical research organizations, and drug manufacturing facilities. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of packaging type, in 2021 the bags & pouches segment dominated the market, in terms of revenue, whereas the others segment is expected to witness growth at the highest CAGR during the forecast period. As per material, in 2021, the plastic segment led the clinical trial packaging market, and the metal segment expected to exhibit highest CAGR in the near future. By end user, the research laboratories segment led the market in 2021, in terms of revenue and the drug manufacturing facilities segment is anticipated to register highest CAGR during the forecast period. Region wise, North America garnered the highest revenue in 2021; however, Asia-Pacific is anticipated to register highest CAGR during the forecast period.

COMPETITION ANALYSIS

The major players profiled in the global clinical trial packaging market include, Almac Group Limited, 3M Company, Bilcare Limited, Corden Pharma International, Thermo Fisher Scientific Inc., Mawdsley-Brooks & Co. Ltd., Parexel International Corporation, Piramal Enterprises Ltd., Sharp Services, LLC, Caligor Coghlan,  Next Pharma Technologies Holding Limited, PCI Pharma Services, Sentry BioPharma Services, Westrock Company, Körber Medipak Systems AG, WuXi AppTec, and Xerimis Inc. Major companies in the market have adopted product launch, partnership, business expansion, and acquisition as their key developmental strategies to offer better products and services to customers in the market.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical trial packaging market analysis from 2021 to 2031 to identify the prevailing clinical trial packaging market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the clinical trial packaging market forecast.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global clinical trial packaging market trends, key players, market segments, application areas, and market growth strategies.

 Clinical Trial Packaging Market Report Highlights